SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-139056
Filing Date
2022-05-04
Accepted
2022-05-03 20:29:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d231081d424b5.htm 424B5 435453
2 GRAPHIC g231081g36y14.jpg GRAPHIC 50066
  Complete submission text file 0001193125-22-139056.txt   500582
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260665 | Film No.: 22889462
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences